CONTRACT MANUFACTURING AGREEMENT TAKES PER.C6 INTO CANADA

Dutch biotechnology company Crucell N.V. announced today that it has signed a PER.C6 contract manufacturing license agreement with the Saskatchewan Research Council (SRC) of Saskatoon, Canada. The agreement allows SRC to sell services to PER.C6 licensees and not-for-profit organisations, for the manufacture of gene therapy products and vaccine products, using PER.C6.

Frankfurter Allgemeine Zeitung (http://www.faz.net/d/invest/meldung.aspx?id=16984841&news=unt)